# OnCo record javelin-merkel-200 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/javelin-merkel-200/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "javelin-merkel-200", "NCT02155647" ;
  schema:name "JAVELIN Merkel 200"@en ;
  schema:description "JAVELIN Merkel 200 showed that the PD-L1 antibody avelumab shrinks about a third of Merkel cell carcinomas that have already failed chemotherapy, most of them durably, and it produced the first approved drug for this cancer."@en ;
  schema:url <https://onco.cc/trials/javelin-merkel-200/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02155647>, <https://doi.org/10.1016/S1470-2045(16)30364-3> ;
  onco:status "positive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/merkel-cell-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/avelumab/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:pathways <https://onco.cc/pathways/oncogenic-viruses/> ;
  onco:people <https://onco.cc/people/howard-kaufman/> .